Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Rowe

Showing results (321-330 of 504) with videos related to

Pageof 51
Sort By:
The Prostate|March 14, 2022
<sup>177</sup> Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysisMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
World Journal of Urology|March 12, 2021
Testicular ultrasound underestimates the size of small testicular masses: a radiologic-pathologic correlation studyZeyad R Schwen, James L Liu, Andrew T Gabrielson, et al.
Tomography (Ann Arbor, Mich.)|December 28, 2018
Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic Resonance ImagesKoshino Kazuhiro, Rudolf A Werner, Fujio Toriumi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2018
Combined model-based and patient-specific dosimetry for <sup>18</sup>F-DCFPyL, a PSMA-targeted PET agentDonika Plyku, Esther Mena, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017
PSMA Ligands for PET Imaging of Prostate CancerSarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.
Medical Oncology (Northwood, London, England)|September 13, 2020
Prospective evaluation of <sup>68</sup>Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA levelLiang Dong, Yinjie Zhu, Mei Xin, et al.
JACC. Cardiovascular Imaging|July 22, 2019
Stability of Distribution of F18 Flurpiridaz After Transient Coronary Occlusion in PigsRudolf A Werner, Kazuhiro Koshino, Kenji Arimitsu, et al.
Molecular Imaging and Biology|September 16, 2018
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [Yafu Yin, Scott P Campbell, Mark C Markowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear MedicineLilja B Solnes, Rudolf A Werner, Krystyna M Jones, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2022
Diagnostic performance of IQ·SPECT with high-speed scanning: A preliminary quality control study in obese patientsRudolf A Werner, Ricardo Bello Martinez, Charles Marcus, et al.
Pageof 51

Showing results (321-330 of 504) with videos related to

Sort By:
Pageof 51
The Prostate|March 14, 2022
<sup>177</sup> Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysisMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
World Journal of Urology|March 12, 2021
Testicular ultrasound underestimates the size of small testicular masses: a radiologic-pathologic correlation studyZeyad R Schwen, James L Liu, Andrew T Gabrielson, et al.
Tomography (Ann Arbor, Mich.)|December 28, 2018
Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic Resonance ImagesKoshino Kazuhiro, Rudolf A Werner, Fujio Toriumi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2018
Combined model-based and patient-specific dosimetry for <sup>18</sup>F-DCFPyL, a PSMA-targeted PET agentDonika Plyku, Esther Mena, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017
PSMA Ligands for PET Imaging of Prostate CancerSarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.
Medical Oncology (Northwood, London, England)|September 13, 2020
Prospective evaluation of <sup>68</sup>Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA levelLiang Dong, Yinjie Zhu, Mei Xin, et al.
JACC. Cardiovascular Imaging|July 22, 2019
Stability of Distribution of F18 Flurpiridaz After Transient Coronary Occlusion in PigsRudolf A Werner, Kazuhiro Koshino, Kenji Arimitsu, et al.
Molecular Imaging and Biology|September 16, 2018
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [Yafu Yin, Scott P Campbell, Mark C Markowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear MedicineLilja B Solnes, Rudolf A Werner, Krystyna M Jones, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2022
Diagnostic performance of IQ·SPECT with high-speed scanning: A preliminary quality control study in obese patientsRudolf A Werner, Ricardo Bello Martinez, Charles Marcus, et al.
Pageof 51